Tokai raises $35.5 million in E round

Tokai Pharmaceuticals Inc. (Cambridge, Mass.) raised $35.5 million in a series E round from existing investors Apple Tree Partners and Novartis Venture Funds, as well as undisclosed angel investors. T...